Aussie Healthcare Daily: 5 Dec 2017
The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...
240 Views
CSL's Largest-Ever Clinical Trial for Recurrent Heart Attacks: High Unmet Medical Need
Blood product giant CSL Ltd (CSL AU) announced during its annual research & development briefing this morning that it will proceed with a Phase...
243 Views
Aussie Healthcare Daily: 1 Dec 2017
The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare & biotech companies as well as developments...
291 Views
Equity Asia Weekly Research - 11 Oct 2017
Mid Term Country Allocation (Tactical view) in terms of Relative Value vs MXAPWhat's new from last week⢠Although ASX remains within its 3-month...
388 Views
Not All Players Are Equal in the Plasma Industry
According to Allied Market Research, the IVIG (intravenous IG) market was valued at US$7.86bn and is expected to reach US$12.36bn by 2022. IVIG is...
421 Views